Latest article
ADA 2021 | Additional assist for insulin degludec to scale back nocturnal hypoglycemia threat...
medwireNews: The use of insulin degludec is associated with a reduced risk...
Novo Nordisk to current analysis throughout diabetes and weight problems portfolio on the 81st...
PLAINSBORO, NJ, June 16, 2021 / PRNewswire / - Novo Nordisk announced that the American Diabetes Association (ADA )’s upcoming 81st Annual Scientific Sessions...